Aurinia Pharmaceuticals shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Aurinia Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Aurinia Pharmaceuticals held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aurinia Pharmaceuticals by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $89k | 18k | 5.01 |
| 2023-12-31 | $163k | 18k | 8.99 |
| 2023-09-30 | $132k | 17k | 7.77 |
| 2023-06-30 | $119k | 12k | 9.68 |
| 2023-03-31 | $129k | 12k | 10.96 |
| 2022-03-31 | $140k | 11k | 12.39 |
| 2021-09-30 | $279k | 13k | 22.14 |
| 2021-06-30 | $363k | 28k | 12.97 |
| 2020-12-31 | $149k | 11k | 13.86 |
| 2020-03-31 | $602k | 42k | 14.51 |
| 2019-12-31 | $576k | 28k | 20.25 |
| 2017-06-30 | $178k | 29k | 6.14 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates